Compare VYGR & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | TAYD |
|---|---|---|
| Founded | 2013 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.6M | 170.7M |
| IPO Year | 2015 | 1995 |
| Metric | VYGR | TAYD |
|---|---|---|
| Price | $3.80 | $57.03 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $16.50 | ★ $70.00 |
| AVG Volume (30 Days) | ★ 613.0K | 39.7K |
| Earning Date | 05-08-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.24 |
| EPS | N/A | ★ 2.87 |
| Revenue | $10,135,000.00 | ★ $46,292,725.00 |
| Revenue This Year | $34.04 | $0.25 |
| Revenue Next Year | $7.92 | $19.78 |
| P/E Ratio | ★ N/A | $19.88 |
| Revenue Growth | N/A | ★ 3.84 |
| 52 Week Low | $2.88 | $40.50 |
| 52 Week High | $5.55 | $90.37 |
| Indicator | VYGR | TAYD |
|---|---|---|
| Relative Strength Index (RSI) | 55.96 | 52.60 |
| Support Level | $3.71 | $56.80 |
| Resistance Level | $3.82 | $59.99 |
| Average True Range (ATR) | 0.16 | 2.74 |
| MACD | 0.02 | 0.16 |
| Stochastic Oscillator | 73.68 | 43.47 |
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.